BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
Deng J, Park D, Wang M, Nooka A, Deng Q, Matulis S, Kaufman J, Lonial S, Boise LH, Galipeau J, Deng X.
Deng J, et al. Among authors: nooka a.
Oncotarget. 2016 May 10;7(19):27753-63. doi: 10.18632/oncotarget.8513.
Oncotarget. 2016.
PMID: 27049723
Free PMC article.